Skip to content

Legal status · United Kingdom

Is Cardiac glycosides legal in the United Kingdom?

Written by Reviewed Sep 2026

ApprovedLongevityStudies in people cited: 2

Direct answer

Yes. Cardiac glycosides is an approved medicine in the United Kingdom. Its legal category is "Licensed, prescription only (MHRA)". The approval covers the use on its label. It is given out on prescription, not sold over the counter. Products labeled "research use only" are not covered by that approval, and that label does not make them legal to use in people. On the evidence, 1 completed human trial is cited on its profile.

People given it
6,800
Found nothing
1

Legal category

Licensed, prescription only (MHRA)

Digoxin only, for heart conditions.

Reviewed Sep 2026. This is a legal category, not legal advice.

A "research use only" label on a vial does not make it legal to use on people.

Cardiac glycosides in the United Kingdom at a glance

Legal categoryLicensed, prescription only (MHRA)
NoteDigoxin only, for heart conditions.
MHRA approval statusApproved by MHRA for the use on its label
Studies in people2 of 6 sources on the profile
ReviewedSep 2026

The legal category and note come from the Cardiac glycosides profile. We checked them against Medicines and Healthcare products Regulatory Agency (MHRA) listings on the reviewed date.

What this means

  • 01

    MHRA has approved Cardiac glycosides for at least one use named on its label. So a proper pharmacy-grade product exists in the United Kingdom, and pharmacies hand it out on prescription.

  • 02

    Approval covers only the uses named on the label. Any other use is a prescriber's call. The approval itself does not cover it.

  • 03

    Unlicensed vials sold online, including those labeled "research use only", are not the approved product. The approval does not cover them.

What Cardiac glycosides is

Two 2019 papers said these heart drugs kill worn-out cells in a dish and in mice. Separately, digoxin was tested for heart failure in one of the biggest heart studies ever, in 6,800 people. That study did not look at worn-out cells. These are two different bodies of proof, and one does not carry over to the other.

Cardiac glycosides are old heart drugs. Digoxin is the best known.

How it works: Shown in human cells in a dish and in mice: blocking the cell's salt pump upsets the charge across the cell wall and makes the inside more acidic. Worn-out cells are already partly upset this way, which may be why they die first.

Approval history: Digoxin is an FDA-approved prescription drug for heart failure and atrial fibrillation, a common irregular heartbeat. openFDA, the FDA's public drug database, lists current prescription products plus several discontinued ones. No drug in this family is approved anywhere to clear worn-out cells or for ageing. Ouabain is not sold as a medicine in the United States.

How MHRA treats this kind of product

Licenses medicines for sale in the UK. A compound without a licence to be sold (a marketing authorisation) is an unlicensed medicine. The law only lets it reach people through a prescriber, under the specials scheme (unlicensed medicines made for one patient's needs). It cannot be sold as a research product.

The legal category above is how The Longevity Archive reads Medicines and Healthcare products Regulatory Agency listings for Cardiac glycosides on the reviewed date. It is not a legal opinion. Rules change. Bringing a compound into the country, prescribing it and owning it can each be treated differently. Check with the agency before you act on anything here.

Check MHRA directly

Cardiac glycosides in sport and the military

Whether Cardiac glycosides is banned in sport is set by the World Anti-Doping Code and by military rules, not by its legal status in the United Kingdom. Before you compete or get tested, look up Cardiac glycosides by name on the Prohibited List, or look up a named product in Global DRO. Under the World Anti-Doping Code, category S0 bans, at all times, any drug-like substance that meets two tests. No other section of the List covers it. And no government health regulator anywhere has a current approval for it as a treatment in people. Many substances that are approved somewhere are banned by name in another section. So approval does not mean a substance is allowed in sport.

The rules you compete or serve under decide this, not this page.

Cardiac glycosides in other countries

Frequently asked questions

Is Cardiac glycosides legal in the United Kingdom?

Yes. Cardiac glycosides is an approved medicine in the United Kingdom. Its legal category is "Licensed, prescription only (MHRA)". The approval covers the use on its label. It is given out on prescription, not sold over the counter. Products labeled "research use only" are not covered by that approval, and that label does not make them legal to use in people. On the evidence, 1 completed human trial is cited on its profile. Note: Digoxin only, for heart conditions.

Can I buy Cardiac glycosides in the United Kingdom?

Only with a prescription. In the United Kingdom, Cardiac glycosides has the legal category "Licensed, prescription only (MHRA)". Pharmacies hand it out with a prescription, for the use it is approved for. Buying it from unlicensed sellers online, or as a "research chemical", is outside that system. You get none of the protection the regulator gives. Note: Digoxin only, for heart conditions.

Is Cardiac glycosides MHRA approved?

Yes, for the use on its label. In the United Kingdom, Cardiac glycosides has the legal category "Licensed, prescription only (MHRA)". For comparison, its US FDA status is: Digoxin is an FDA-approved prescription drug for heart failure and atrial fibrillation, a common irregular heartbeat. openFDA, the FDA's public drug database, lists current prescription products plus several discontinued ones. No drug in this family is approved anywhere to clear worn-out cells or for ageing. Ouabain is not sold as a medicine in the United States.. On the evidence, 1 completed human trial is cited on its profile.

Related compounds in the United Kingdom

Full research profile

How Cardiac glycosides works, the studies we cite, FDA status and the full legal summary are all on its compound profile.

Cardiac glycosides profile

This page is general information about the legal status of Cardiac glycosides in the United Kingdom, current as of Sep 2026. It is not legal advice. Legal status changes. For your own situation, check with Medicines and Healthcare products Regulatory Agency or ask a lawyer. Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.